In this issue:
Ambulatory management of secondary spontaneous pneumothorax
Switching PDE-5 inhibitor to riociguat in PAH
Iron supplementation in PAH
Current smoking and COVID-19 risk
Connected inhaler systems and medication adherence in uncontrolled asthma
Lung microbiota predict chronic rejection in healthy lung transplant recipients
Low FeNO excludes short-term ICS benefit in suspected asthma
Cost-effectiveness of benralizumab for severe asthma
Protective ventilation strategies for moderate-to-severe ARDS
Fevipiprant for uncontrolled asthma
Please login below to download this issue (PDF)